Showing results (151-160 of 617) with videos related to

Sort By:
Pageof 62
Leukemia Research|December 3, 2014
Chronic mast cell leukemia: a novel leukemia-variant with distinct morphological and clinical featuresPeter Valent, Karl Sotlar, Wolfgang R Sperr, et al.
Journal of Thrombosis and Haemostasis : JTH|January 31, 2020
The prevention and management of asparaginase-related venous thromboembolism in adults: Guidance from the SSC on Hemostasis and Malignancy of the ISTHJeffrey I Zwicker, Tzu-Fei Wang, Daniel J DeAngelo, et al.
Haematologica|June 14, 2006
A combination of cytomorphology, cytogenetic analysis, fluorescence in situ hybridization and reverse transcriptase polymerase chain reaction for establishing clonality in cases of persisting hypereosinophiliaUlrike Bacher, Andreas Reiter, Torsten Haferlach, et al.
Blood Cancer Journal|December 20, 2023
Sociodemographic associations with uptake of novel therapies for acute myeloid leukemiaAndrew Hantel, Colin Cernik, Hajime Uno, et al.
Blood Advances|January 28, 2026
Efficacy and safety of avapritinib in advanced systemic mastocytosis: 4-year follow-up of the PATHFINDER studyJason Gotlib, Andreas Reiter, Deepti H Radia, et al.
American Journal of Hematology|November 5, 2011
Tailored temozolomide therapy according to MGMT methylation status for elderly patients with acute myeloid leukemiaBruno C Medeiros, Holbrook E Kohrt, Jason Gotlib, et al.
The Oncologist|August 12, 2025
Barriers and Facilitators to Representative Acute Leukemia Trial Participation at National Cancer Institute-Designated Comprehensive Cancer CentersAndrew Hantel, Eric C Blackstone, Anna C Revette, et al.
Therapeutic Advances in Hematology|January 3, 2017
Exploratory study on the impact of switching to nilotinib in 18 patients with chronic myeloid leukemia in chronic phase with suboptimal response to imatinibSikander Ailawadhi, Luke P Akard, Carole B Miller, et al.
Seminars in Oncology|May 3, 2008
Optimizing outcomes for patients with advanced disease in chronic myelogenous leukemiaFrancis J Giles, Daniel J DeAngelo, Michele Baccarani, et al.
NEJM Evidence|August 26, 2025
Pemigatinib for Myeloid/Lymphoid Neoplasms with FGFR1 RearrangementSrdan Verstovsek, Jean-Jacques Kiladjian, Alessandro M Vannucchi, et al.
Pageof 62